Dan Lynch


Daniel S. Lynch is the Chair of the Board of Directors at Xilio Therapeutics and a strategic advisor at Third Rock Ventures. He brings more than 25 years of experience in biotechnology and pharmaceutical companies and has active board roles in several companies including chairman at bluebird bio, Blueprint Medicines, and Translate Bio (formerly ...

Roles at Xilio Therapeutics

  • Chair

    Current role

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.